JBSC Membership Program
Advancing brain and spinal tumor research through collaborative publication excellence.
Uniting the Neuro-Oncology Research Community
The Journal of Brain and Spinal Cancer membership program connects neurosurgeons, neuro-oncologists, and researchers dedicated to advancing understanding, diagnosis, and treatment of central nervous system tumors.
Members gain reduced publication costs, priority review processing, and access to a global network of CNS oncology professionals working to improve patient outcomes worldwide.
Individual Member
- 15% discount on article processing charges
- Priority peer review processing
- Full access to JBSC archive
- Quarterly research digest newsletter
- Member directory listing
- Digital membership certificate
Institutional Partner
- 25% discount on APCs for affiliated authors
- Expedited review for institutional submissions
- Unlimited researcher coverage
- Dedicated institutional liaison
- Annual publication metrics report
- Featured institution profile
- Priority special issue consideration
Lifetime Fellow
- 30% lifetime APC discount
- Fast-track manuscript review
- Editorial board invitation consideration
- Speaking opportunities at JBSC events
- Recognition in fellows directory
- Complimentary language editing
Accelerated Publication
Fast-track your neuro-oncology research from submission to publication. Priority processing ensures your clinical findings and molecular discoveries reach neurosurgeons and oncologists promptly.
Research Investment
Significant APC savings across all membership tiers allow you to redirect resources toward clinical trials, laboratory investigations, and translational research rather than publication expenses.
Global Network
Connect with neurosurgeons, neuro-oncologists, radiation oncologists, and neuropathologists worldwide. Share insights across glioblastoma, meningioma, spinal cord tumors, and metastatic disease.
Professional Recognition
Demonstrate your commitment to advancing CNS cancer knowledge. Fellows contribute expert perspectives on emerging diagnostics and novel therapeutic approaches.
Joining the JBSC community is straightforward. Email [email protected] with your professional credentials, institutional affiliation, research specialty, and preferred membership tier. Our team reviews applications within 5 business days. Comprehensive cancer centers and institutional partners receive personalized onboarding maximizing benefits across their neuro-oncology teams.
Developing Nation Support: Brain and spinal cancer researchers from low and middle-income countries may qualify for reduced membership fees. JBSC ensures economic barriers do not prevent clinician-scientists from contributing to global neuro-oncology advancement.
ManuscriptZone Portal
Submit through oap.manuscriptzone.net for comprehensive manuscript tracking, reviewer communication, and revision management.
Simple Submission Form
Use our streamlined online form for rapid manuscript upload when you need a direct submission pathway.
JBSC membership supports research across CNS malignancy disciplines including glioblastoma, astrocytoma, oligodendroglioma, meningioma, ependymoma, spinal cord tumors, brain metastases, pediatric brain tumors, molecular neuro-oncology, immunotherapy, and radiosurgery. Members publishing CNS oncology research receive full tier benefits.
Brain and spinal cancer treatment requires multidisciplinary expertise spanning neurosurgery, neuro-oncology, radiation oncology, neuropathology, and rehabilitation. JBSC membership facilitates connections strengthening collaborative approaches translating into improved patient outcomes.
Membership status never influences editorial decisions. All member submissions undergo identical peer review scrutiny and must meet rigorous scientific standards. Publication decisions rest solely on scientific merit and clinical importance.
Members gain opportunities to engage with emerging clinical trial networks advancing brain and spinal cancer therapeutics. From novel immunotherapies to targeted molecular agents, membership connects researchers with the evolving landscape of CNS tumor treatment innovation and experimental protocols.
JBSC recognizes the importance of patient perspectives in research direction. Members contribute to publishing research addressing quality of life, neurocognitive outcomes, and survivorship issues that directly impact patients and families affected by brain and spinal malignancies.
The journal emphasizes translational research bridging laboratory discoveries with clinical applications. Members working across the bench-to-bedside spectrum benefit from a community spanning basic science, preclinical models, and clinical investigations advancing neuro-oncology therapeutics.
Join the Neuro-Oncology Community
Partner with researchers dedicated to advancing brain and spinal cancer treatment.